Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer

NCT03367182 · clinicaltrials.gov ↗

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Weekly paclitaxel
DRUG: Topotecan
DRUG: Pegylated liposomal doxorubicin
DRUG: Bevacizumab

Sponsor

Yonsei University